Physician profile
William Wunder
NPI 1750464020
$1,728.06
in general payments reported to CMS, 2019-2025
24 companies · $90.67 in 2025
The $90.67 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,094 · 2020: $198 · 2021: $5.75 · 2023: $94.25 · 2024: $246 · 2025: $90.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $431.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $430.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $279.93 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Amarin Pharma, INC. | $156.00 | 2019-2020 | |
| Arbor Pharmaceuticals, INC. | $144.95 | 2019 | |
| Glaxosmithkline, LLC. | $137.19 | 2019-2023 | Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $108.69 | 2019 | |
| Lilly USA, LLC | $98.33 | 2019-2024 | Mounjaro |
| Janssen Pharmaceuticals, INC | $95.69 | 2019-2020 | |
| Astellas Pharma US INC | $79.07 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $78.10 | 2019-2020 | |
| Allergan, INC. | $77.59 | 2019-2020 | |
| Pfizer INC. | $76.04 | 2019-2024 | |
| Exact Sciences Corporation | $70.57 | 2023-2025 | Cologuard Collection Kit |
| Takeda Pharmaceuticals U.S.A., INC. | $66.42 | 2019 | |
| Amgen INC. | $59.24 | 2019-2023 | Repatha, Otezla |
| Merck Sharp & Dohme LLC | $34.60 | 2019-2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $26.35 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $24.58 | 2019-2020 | |
| Abbvie INC. | $24.07 | 2024 | |
| Jazz Pharmaceuticals INC. | $23.07 | 2019 | |
| Southern Edge Orthopaedics, INC. | $19.75 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $16.75 | 2020 | |
| Ironwood Pharmaceuticals, INC | $13.42 | 2020 | |
| Mylan Specialty L.P. | $11.91 | 2019 | |
| Clarus Therapeutics INC. | $5.75 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Wunder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.